What is it about?
In the present research, an effective drug-free approach was developed to kill MCF7 breast cancer cells using low-level laser therapy (LLLT) combined with reduced graphene oxide (rGO)-based hybrid nanocomposites (NCs). Here, fruit extract of Rosa canina was used for the first time to obtain the rGO/ZnO, Ag-ZnO/rGO and Nd-ZnO/rGO NCs by green synthesis.
Featured Image
Why is it important?
The results show the potential of using rGO-based NCs in LLLT, which may be combined with other therapeutic approaches to assist our fight against cancer.
Read the Original
This page is a summary of: A novel non-invasive strategy for low-level laser-induced cancer therapy by using new Ag/ZnO and Nd/ZnO functionalized reduced graphene oxide nanocomposites, Artificial Cells Nanomedicine and Biotechnology, May 2018, Taylor & Francis,
DOI: 10.1080/21691401.2018.1470523.
You can read the full text:
Contributors
The following have contributed to this page
